Immuron board changes

Melbourne, australia, may 31, 2024 (globe newswire) -- immuron limited (asx: imc; nasdaq: imrn), an australian based and globally integrated biopharmaceutical company, advises that dr roger aston has resigned from his position as non-executive director effective today.
IMRN Ratings Summary
IMRN Quant Ranking